GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
13.1802 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, PPARA, SLC6A3, SMAD3, SRC, TEK, TYR |
10.2404 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MMP12, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.4115 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MMP12, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.4115 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, INSR, PPARA, SLC6A3, SRC, TEK, TYR |
9.4115 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
9.0073 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.89011 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESRRA, FLT3, HSD11B2, SLC6A3, SRC, TEK, TYR |
8.8627 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.79754 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA |
7.63542 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, NUAK1, SMAD3, SRC, TEK, XDH |
7.41033 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, MMP12, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.33507 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD2, DRD3, DRD4, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.26092 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD2, DRD3, DRD4, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.26092 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.0971 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, EGFR, GRIK5, INSR, SLC1A1, SLC6A2, SLC6A3, SMAD3 |
6.95625 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.94807 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, INSR, PPARA, SRC, TEK |
6.91392 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.90627 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GRM5, HSD11B2, IGF1R, INSR, PPARA, SMAD3, SRC, TEK |
6.86385 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.80673 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.80673 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTPN1, SLC1A1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.71261 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
6.69575 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.6388 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, SRC, TYR |
6.47345 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.44104 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3 |
6.42965 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
6.42221 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, BCL2, CYP1B1, DRD2, DRD4, EGFR, F3, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, PTPN1, SRC, TEK, XDH |
6.22221 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.19623 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3, SRC |
6.18656 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD2, EGFR, GRM1, GRM3, GRM5, GRM8 |
6.06665 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F3, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK, XDH |
6.0433 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F3, GPR35, GRIK5, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TEK |
6.02244 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, BCL2, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
5.91797 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
5.89261 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESRRA, F3, FABP4, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, MMP12, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.87825 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.87337 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.87337 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALPL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESRRB, F3, FABP4, GRM1, GRM5, GRM8, HSD11B2, HSD17B2, IGF1R, INSR, MET, MMP12, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS2, TYR |
5.75801 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, HSPA1A, SLC6A3 |
5.69229 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FABP3, HSD11B2, KDR, SLC6A2, SLC6A3, SRC |
5.63216 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, GRM5, HSD11B2, IGF1R, INSR, PPARA, SLC6A3, SRC, TEK, TYR |
5.44937 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
5.44889 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
5.40041 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, DRD3, DRD4, SLC6A3, TYR |
5.3698 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD2, DRD3, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
5.3698 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, CDK6, DRD2, DRD3, EGFR, HCAR2, KDR, SRC, TNKS, TNKS2 |
5.3698 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP12, NUAK1, PPARA, PTPN1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
5.24284 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.23621 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.23194 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.11686 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, GBA2, SLC6A3, TYR |
5.09348 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, GRM5, HSD11B2, IGF1R, INSR, PPARA, SLC6A3, SRC, TEK, TYR |
5.0766 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
5.06762 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CDK6, CYP19A1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, XDH |
4.99818 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, MET, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
4.99108 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, GRM1, GRM5, INSR, KDR, PTPN1, SMAD3, SRC, TEK, XDH |
4.86791 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, GRM1, GRM5, INSR, KDR, PTPN1, SMAD3, SRC, TEK, XDH |
4.86791 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, BCL2, CDC25B, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.79018 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
4.75758 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
DRD2, DRD3, EGFR, F3, INSR, MET, SRC, TEK, XDH |
4.75758 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.75335 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, IGF1R, INSR, KDR, MMP12, TEK |
4.69098 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.68412 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.6799 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.67187 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, SLC6A3, SRC |
4.66498 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.66498 |
[BP] GO:0007188 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
4.66498 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.66413 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, GPR35, GRM1, GRM5, SMAD3 |
4.6394 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, KDR, MET, MMP12, PPARA, SLC6A3, SMAD3, TEK |
4.62444 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
4.6058 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.5662 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CDK6, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, MMP12, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.51125 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.48733 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.42353 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MET, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.40142 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, KDR, SLC6A3, SRC |
4.39242 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, INSR, KDR, PPARA, SLC6A3, SMAD3, SRC, TEK, TYR |
4.36392 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.36392 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, ESRRB, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KDR, PPARA, PTPN1, SRC, TEK, XDH |
4.3491 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.33915 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, DRD2, DRD4, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
4.33157 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, BCL2, CA2, CDK6, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MMP12, SLC1A1, SLC6A3, SMAD3, SRC, TEK, TNKS2, XDH |
4.31086 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
4.29847 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MET, PTPN1, SMAD3, SRC, TEK, XDH |
4.29847 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, DRD2, DRD4, EGFR, FLT3, GRM1, INSR, KDR, PTPN1, SRC, TEK, XDH |
4.29847 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, PTPN1, SRC, TEK |
4.26453 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD2, DRD3, DRD4, SLC6A3 |
4.26348 |
[BP] GO:0007187 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
4.24886 |
[BP] GO:0060078 |
None
|
ADORA1, DRD4, GRIA2, GRIA4, GRIK5, GRM5 |
4.2084 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.202 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FLT3, GRM1, GRM5, INSR, KDR, PTPN1, SRC, TEK, XDH |
4.18778 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, PPARA, SMAD3, SRC, TEK |
4.17917 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DRD4, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, PTPN1, SRC |
4.17917 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.16275 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, HSPA1A, PPARA, TYR, XDH |
4.16145 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
4.12652 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, BCL2, CA2, CYP1A1, DRD2, DRD3, EGFR, GRM1, HSD11B2, HSPA1A, PPARA, SMAD3, SRC, TEK, TYR |
4.12652 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
4.12384 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.12254 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.12254 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, INSR, KDR, MET, PPARA, SLC6A3, SMAD3, SRC, TEK, TNKS2, TYR |
4.10922 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, PTPN1, SMAD3, SRC, XDH |
4.10248 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, PPARA, SMAD3, SRC, TEK |
4.10157 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, PTPN1, SMAD3, SRC, XDH |
4.08903 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.08717 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, PTPN1, SRC, TEK, TNKS |
4.08643 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, SRC, TEK |
4.08444 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, ESR2, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, MET, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
4.08237 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, PTPN1, SRC, TEK |
4.06266 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GRM3, GRM8, HSPA1A, IGF1R, KDR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.06266 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1, SLC6A2, SLC6A3 |
4.03703 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, ESR1, FABP4, GPR35, GRM3, IGF1R, MET, PPARA, PTPN1, SRC, TNKS |
4.01329 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.01261 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GRM3, GRM8, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP12, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.98782 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.97823 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, KDR, PTPN1, SMAD3, SRC, TEK, XDH |
3.97823 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, PTPN1, SRC |
3.96768 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.94129 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.93834 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, PPARA, SRC |
3.93834 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD2, DRD3, KDR, SRC |
3.93834 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, SMAD3, SRC |
3.91748 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.91748 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.91748 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, CDC25B, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, PTPN1, SRC, TEK, TNKS |
3.90729 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.87821 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, PPARA, SMAD3, SRC, TEK |
3.87286 |
[BP] GO:0007268 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.86567 |
[BP] GO:0098916 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.86567 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, PTPN1, SMAD3, SRC, TEK, XDH |
3.85257 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, INSR, KDR, SMAD3, SRC |
3.82957 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, KDR, PTPN1, SRC, TEK, XDH |
3.82176 |
[BP] GO:0099536 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.79565 |
[BP] GO:0099537 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.79565 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
3.76086 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, KDR, PTPN1, SMAD3, SRC, TEK, XDH |
3.76086 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP3, FABP4, FUT7, GBA2, MET, PPARA |
3.73678 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, BCL2, CA2, CA7, CYP19A1, DRD2, DRD3, DRD4, EGFR, GPR35, GRIK5, GRM5, HCAR2, HSPA1A, INSR, MMP12, PPARA, PTPN1, SMAD3, SRC |
3.73678 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TNKS, TNKS2, XDH |
3.73257 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, DRD2, DRD3, EGFR, HCAR2, TNKS, TNKS2 |
3.72627 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.72289 |
[BP] GO:0042391 |
None
|
ADORA1, BCL2, DRD4, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.6965 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.63386 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.62964 |
[BP] GO:1900542 |
None
|
DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8, INSR, PPARA |
3.62757 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, PTPN1, SRC |
3.59486 |
[BP] GO:0007267 |
None
|
ADORA1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2, TEK |
3.5777 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, PTPN1, SRC, XDH |
3.57726 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
3.56788 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.55954 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.55954 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
3.55954 |
[BP] GO:0006140 |
None
|
DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8, INSR, PPARA |
3.55919 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
3.51937 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
3.51841 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTPN1, SRC, TEK, XDH |
3.50256 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.4963 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
3.45048 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK, TNKS, XDH |
3.42796 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRIK5, GRM1, GRM5, SMAD3 |
3.42796 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.37378 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, DRD3, SLC6A3, TNKS2 |
3.35367 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.35367 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP12, PPARA, PTPN1, SMAD3, SRC, TEK |
3.35367 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, GRM5, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK |
3.33919 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2, SLC6A3 |
3.33773 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, DRD4, EGFR, FLT3, GRM1, INSR, PTPN1, SRC |
3.30801 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD2, DRD4, EGFR |
3.30386 |
[BP] GO:0007194 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.28879 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.28879 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.28611 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.28611 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.28611 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
3.28113 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.26985 |
[BP] GO:0006468 |
protein phosphorylation
|
BCL2, CDC25B, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
3.26985 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.26985 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
3.26967 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.25942 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.25291 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FLT3, HCAR2, PPARA, SRC, TEK |
3.23387 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESRRB, F3, HCAR2, HSPA1A, KDR, MET, MMP12, SLC1A1, SLC6A3, SMAD3, SRC, TEK |
3.23084 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.23084 |
[BP] GO:0031280 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.20896 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, PPARA, PTPN1, SMAD3, SRC, TEK |
3.20845 |
[BP] GO:0023052 |
None
|
ADORA1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2, TEK |
3.18957 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
3.18783 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.18644 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.18242 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK, TNKS, XDH |
3.18242 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, PPARA, SLC6A3, SMAD3, TEK |
3.18242 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.17423 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, BCL2, CA2, CYP19A1, DRD2, DRD3, DRD4, EGFR, HCAR2, INSR, MMP12, SMAD3, SRC |
3.16432 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.15377 |
[BP] GO:0051350 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.13057 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.12806 |
[BP] GO:0045936 |
None
|
DRD2, DRD3, DRD4, DUSP3, FABP4, GRM3, GRM8, IGF1R, PPARA, PTPN1, XDH |
3.12526 |
[BP] GO:0010563 |
None
|
DRD2, DRD3, DRD4, DUSP3, FABP4, GRM3, GRM8, IGF1R, PPARA, PTPN1, XDH |
3.12009 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
3.10235 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, MMP12, SRC |
3.09493 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTPN1, SMAD3, SRC |
3.0914 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.08157 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
3.00322 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, DRD4, GPR35 |
2.99431 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.9918 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
BCL2, DRD3, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.98723 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.98376 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
2.98376 |
[BP] GO:0007154 |
None
|
ADORA1, BCL2, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2, TEK |
2.98376 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, PTPN1, SMAD3, SRC, TEK |
2.98376 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DRD4, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, PTPN1, SRC |
2.98288 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.98288 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.97912 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, SRC, TNKS, TNKS2 |
2.96168 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
2.95952 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, SRC |
2.9473 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.9017 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.90021 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.90021 |
[BP] GO:0008217 |
None
|
ADORA1, DRD2, DRD3, HSD11B2, PPARA, SMAD3 |
2.88834 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, DRD2, DRD3, EGFR, GPR35, GRM1, HCAR2, SLC1A1, SMAD3 |
2.88556 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.86951 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, DRD2, DRD4, EGFR, GRM1, INSR, PTPN1, SRC |
2.86951 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, PTPN1, SMAD3, SRC, XDH |
2.85254 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F3, INSR, MET, SRC, TEK |
2.84842 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, SLC6A3 |
2.82783 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, SRC |
2.80542 |
[BP] GO:0045761 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.80542 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, KDR, SMAD3, TEK |
2.80542 |
[BP] GO:0040008 |
regulation of growth
|
BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, SLC6A3, SMAD3, TNKS2 |
2.79588 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.79241 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, BCL2, CDC25B, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, KDR, PTPN1, SRC, TEK, XDH |
2.77111 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
2.77111 |
[BP] GO:0019725 |
cellular homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRIK5, GRM1, GRM5, SMAD3 |
2.76775 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
BCL2, CDC25B, CDK6, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, SMAD3, TNKS |
2.76775 |
[BP] GO:0007610 |
None
|
BCL2, DRD2, DRD3, DRD4, EGFR, GRM1, GRM5, INSR, PPARA, SLC6A3 |
2.76775 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4 |
2.75122 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, F3, KDR, MMP12, SMAD3, TEK, XDH |
2.74735 |
[BP] GO:0055065 |
metal ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.74108 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 |
2.74108 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.71725 |
[BP] GO:0030817 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.7048 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, DRD4, PPARA |
2.7048 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, BCL2, CYP1B1, DRD2, DRD3, EGFR, GRM1, GRM5, GRM8, HSD11B2, INSR, SLC6A3, SRC, TEK, TYR |
2.70043 |
[BP] GO:1901386 |
None
|
DRD2, DRD4, GPR35 |
2.6849 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A3 |
2.6849 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TNKS, TNKS2 |
2.67934 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.66242 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, DRD4, EGFR, GRIK5, HCAR2, MMP12, SRC |
2.65556 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, PTPN1, SMAD3, SRC |
2.65523 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
2.64762 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.63883 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.6347 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, SRC |
2.61908 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.61908 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HSPA1A, IGF1R, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TNKS, TNKS2, XDH |
2.61244 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.60071 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, MMP12, SRC |
2.60023 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.60023 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.60023 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.60023 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.60023 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.60023 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.60023 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, DRD4, EGFR, FLT3, GRM1, INSR, PTPN1, SRC |
2.60023 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.58401 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
2.58227 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.58021 |
[BP] GO:0045934 |
None
|
DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HSPA1A, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.57536 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.57536 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.57536 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.57536 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.56853 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.56766 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.56766 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.56766 |
[BP] GO:0051172 |
None
|
CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HSPA1A, IGF1R, MMP12, PPARA, PTPN1, SMAD3, SRC, TNKS, TNKS2, XDH |
2.56478 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.54631 |
[BP] GO:0007626 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM5, SLC6A3 |
2.54288 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, CA2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM3, GRM5, GRM8, HCAR2, INSR, SRC |
2.52714 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.51946 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.51946 |
[BP] GO:0010564 |
regulation of cell cycle process
|
BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, TNKS |
2.50024 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, PTPN1, SMAD3, SRC, TEK |
2.49076 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.48804 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.47609 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SRC |
2.46761 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, SRC |
2.46761 |
[BP] GO:0016310 |
phosphorylation
|
BCL2, CDC25B, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
2.46761 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.46761 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.46761 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.46625 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
DRD2, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
2.45668 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.45007 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
BCL2, CDK6, KDR, SMAD3, SRC, TEK |
2.44816 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.44814 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, DRD4, EGFR, GRIK5, HCAR2, MMP12, SRC |
2.44089 |
[BP] GO:0030814 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.43677 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
2.43382 |
[BP] GO:0051726 |
regulation of cell cycle
|
BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, SMAD3, SRC, TNKS |
2.4259 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.41928 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
BCL2, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.40939 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, HSPA1A, MMP12, SLC6A3, SRC, XDH |
2.40571 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.40384 |
[BP] GO:0031279 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.40196 |
[BP] GO:0030802 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.39645 |
[BP] GO:0051339 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.37802 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, PTPN1, SRC, TEK |
2.37802 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.37802 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.37802 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.37802 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.37802 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.37802 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.37802 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.37802 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.37802 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK |
2.3724 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.34581 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.33038 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.33038 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.31652 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
BCL2, DRD2, DRD4, GPR35 |
2.31652 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.2813 |
[BP] GO:0050793 |
regulation of developmental process
|
BCL2, CA2, CDK6, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, INSR, KDR, NUAK1, PPARA, SLC6A3, SMAD3, SRC, TEK, TNKS2, XDH |
2.26657 |
[BP] GO:1900371 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.25858 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.24723 |
[BP] GO:0030808 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.24589 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.24062 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.24062 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.24062 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.24062 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.24062 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.23177 |
[BP] GO:0015718 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
2.22288 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, BCL2, CYP1A1, EGFR, ESR1, FLT3, MET, SRC, TEK, TYR |
2.21768 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.20687 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.19671 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.19345 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.19345 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.19345 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.19345 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.19345 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.19345 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.17285 |
[BP] GO:0030155 |
regulation of cell adhesion
|
BCL2, CDK6, CYP1B1, DUSP3, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.15036 |
[BP] GO:0050708 |
None
|
ACHE, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, SRC |
2.14635 |
[BP] GO:0032868 |
None
|
FABP3, HSD11B2, INSR, PPARA, SRC |
2.13545 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2 |
2.13545 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, PTPN1, SMAD3, SRC, TEK |
2.12898 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.12115 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.12115 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, DRD4, GPR35 |
2.11476 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
2.11439 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.1047 |
[BP] GO:0030799 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.0998 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.09727 |
[BP] GO:0051952 |
None
|
ADORA1, DRD2, DRD3, DRD4 |
2.09727 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.08516 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.08516 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.08516 |
[BP] GO:0046717 |
None
|
DRD2, DRD3, DRD4, SLC1A1 |
2.07909 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
CDC25B, CYP1A1, DRD3, DUSP3, INSR |
2.07903 |
[BP] GO:0070201 |
None
|
ACHE, BCL2, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, PTPN1, SMAD3, SRC |
2.07903 |
[BP] GO:0022898 |
None
|
BCL2, DRD2, DRD3, DRD4, GPR35, GRM5 |
2.07821 |
[BP] GO:0009410 |
None
|
DRD2, DRD3, DRD4, EGFR, SLC6A3 |
2.06004 |
[BP] GO:0050730 |
None
|
ADORA1, EGFR, FLT3, GRM5, PTPN1, SRC |
2.06004 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, SLC6A3 |
2.06004 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.06004 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.06004 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.06004 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.06004 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.06004 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.06004 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.06004 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.06004 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.06004 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.06004 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, EGFR, HCAR2, MMP12, SRC |
2.02651 |
[BP] GO:0040018 |
None
|
BCL2, DRD2, SLC6A3 |
2.02538 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.02538 |
[BP] GO:0001763 |
morphogenesis of a branching structure
|
BCL2, DRD2, ESR1, MET, SRC |
2.01947 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, BCL2, CDK6, CYP1B1, DRD2, FABP3, HSPA1A, SMAD3, XDH |
2.01947 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, MMP12, PPARA, SLC1A1, SLC6A2, SLC6A3, TNKS |
2.01014 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5 |
2.00292 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, TYR |
2.00292 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.00292 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, CA4, DRD2, DRD3, DRD4, F3, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TEK |
5.69229 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, DRD2, EGFR, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, SLC1A1, SRC, TEK |
5.51947 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, F3, FLT3, GBA2, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PTPN1, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK |
5.44141 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, CA2, CA4, CA9, DRD2, DRD3, DRD4, DUSP3, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SRC, TEK |
5.3698 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MET, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TEK, TYR |
4.99818 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, DRD2, DRD3, DRD4, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TEK |
4.72385 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALPL, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MET, PTPN1, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TYR |
4.35243 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, DRD2, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A3, SRC |
3.85257 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.50169 |
[CC] GO:0014069 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
3.18242 |
[CC] GO:0099572 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
3.18242 |
[CC] GO:0098794 |
None
|
ADORA1, DRD2, DRD4, GRIA2, GRIA4, GRM3 |
2.84842 |
[CC] GO:0043235 |
receptor complex
|
EGFR, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 |
2.80542 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
2.74048 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, CDK6, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC, TEK |
2.7048 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ALPL, CA12, CA14, CA4, CA9, DRD2, DRD3, DRD4, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TEK, TYR |
2.60023 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
2.58401 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.46761 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CDK6, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC, TEK |
2.46761 |
[CC] GO:0043197 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.40939 |
[CC] GO:0044309 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.3803 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.36503 |
[CC] GO:0045121 |
membrane raft
|
EGFR, INSR, KDR, SLC6A2, SLC6A3, SRC, TEK |
2.31531 |
[CC] GO:0098857 |
membrane microdomain
|
EGFR, INSR, KDR, SLC6A2, SLC6A3, SRC, TEK |
2.29795 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ALPL, CA12, CA14, CA9, DRD2, DRD3, DRD4, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TEK, TYR |
2.0745 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.06004 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.56033 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
9.4115 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, CDK6, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
9.0073 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
8.63129 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK |
8.50252 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.13432 |
[MF] GO:0046914 |
transition metal ion binding
|
AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP12, PPARA, PTPN1, SMAD3, TNKS, TYR, XDH |
7.768 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, TEK |
6.72708 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, TEK |
6.72708 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPN1, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
6.63889 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.23614 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
6.13762 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
5.93957 |
[MF] GO:0030594 |
None
|
DRD2, DRD3, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
5.66988 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.44937 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTPN1, SRC, TEK, TNKS, TNKS2, TYR, XDH |
5.44889 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
5.35411 |
[MF] GO:0008144 |
drug binding
|
ACHE, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PPARA, SLC6A3, SRC, TEK |
4.65894 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.61507 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP12, PPARA, PTPN1, SMAD3, TNKS |
4.45339 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.32946 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.27458 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.27458 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
4.00195 |
[MF] GO:1901338 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.97823 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, PPARA, PTPN1, SLC6A3, SMAD3, SRC |
3.94441 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.91748 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.91748 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.78395 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, PPARA, PTPN1, SLC6A3, SMAD3, SRC |
3.62757 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SLC6A3, SMAD3 |
3.60809 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.59486 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.57891 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.55954 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.54929 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, MMP12, NUAK1, PPARA, PTPN1, SLC1A1, SLC6A2, SLC6A3, SMAD3, TNKS, TNKS2, TYR, XDH |
3.50326 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.43721 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.41211 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.33889 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, SLC6A3 |
3.21025 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
3.08264 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.98288 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.98288 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.95021 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.83568 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.80542 |
[MF] GO:0004672 |
protein kinase activity
|
CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.79588 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.75596 |
[MF] GO:0005506 |
iron ion binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
2.74893 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.60023 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.60023 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.57536 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.57536 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.55535 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, BCL2, CSNK2A1, DRD2, DRD4, EGFR, ESR1, ESR2, FLT3, GRIK5, IGF1R, KDR, MET, SMAD3, TYR, XDH |
2.48917 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HSD17B1, SRC, XDH |
2.45729 |
[MF] GO:0019899 |
enzyme binding
|
BCL2, CDC25B, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, GRM5, HSPA1A, MET, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS2 |
2.42638 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, MET, PTPN1, SLC6A3 |
2.40939 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.37802 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.37802 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.27244 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.24589 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.23258 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.19345 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.19345 |
[MF] GO:0051721 |
None
|
BCL2, PTPN1, SLC6A3 |
2.15863 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.1472 |
[MF] GO:0008289 |
lipid binding
|
ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA |
2.12115 |
[MF] GO:0046872 |
metal ion binding
|
ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP12, NUAK1, PPARA, PTPN1, SLC1A1, SLC6A2, SLC6A3, SMAD3, TNKS, TNKS2, TYR, XDH |
2.07527 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.06004 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.06004 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.06004 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.06004 |